NM_004924.6:c.978G>A
Variant names: 
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_004924.6(ACTN4):c.978G>A(p.Gln326Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00155 in 1,614,252 control chromosomes in the GnomAD database, including 75 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
 Genomes: 𝑓 0.0027   (  11   hom.,  cov: 33) 
 Exomes 𝑓:  0.0014   (  64   hom.  ) 
Consequence
 ACTN4
NM_004924.6 synonymous
NM_004924.6 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.508  
Publications
1 publications found 
Genes affected
 ACTN4  (HGNC:166):  (actinin alpha 4)  Alpha actinins belong to the spectrin gene superfamily which represents a diverse group of cytoskeletal proteins, including the alpha and beta spectrins and dystrophins.  Alpha actinin is an actin-binding protein with multiple roles in different cell types.  In nonmuscle cells, the cytoskeletal isoform is found along microfilament bundles and adherens-type junctions, where it is involved in binding actin to the membrane.  In contrast, skeletal, cardiac, and smooth muscle isoforms are localized to the Z-disc and analogous dense bodies, where they help anchor the myofibrillar actin filaments.  This gene encodes a nonmuscle, alpha actinin isoform which is concentrated in the cytoplasm, and thought to be involved in metastatic processes.  Mutations in this gene have been associated with focal and segmental glomerulosclerosis. [provided by RefSeq, Jul 2008] 
ACTN4 Gene-Disease associations (from GenCC):
- focal segmental glomerulosclerosis 1Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
 - familial idiopathic steroid-resistant nephrotic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53). 
BP6
Variant 19-38717151-G-A is Benign according to our data. Variant chr19-38717151-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 259584.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BP7
Synonymous conserved (PhyloP=-0.508 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00273 (416/152382) while in subpopulation AMR AF = 0.0237 (363/15302). AF 95% confidence interval is 0.0217. There are 11 homozygotes in GnomAd4. There are 235 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check. 
BS2
High AC in GnomAd4 at 416 AD gene. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| ACTN4 | NM_004924.6  | c.978G>A | p.Gln326Gln | synonymous_variant | Exon 10 of 21 | ENST00000252699.7 | NP_004915.2 | 
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.00275  AC: 418AN: 152264Hom.:  11  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
418
AN: 
152264
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.00581  AC: 1459AN: 251260 AF XY:  0.00436   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
1459
AN: 
251260
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.00142  AC: 2082AN: 1461870Hom.:  64  Cov.: 32 AF XY:  0.00123  AC XY: 898AN XY: 727242 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
2082
AN: 
1461870
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
898
AN XY: 
727242
show subpopulations 
African (AFR) 
 AF: 
AC: 
14
AN: 
33480
American (AMR) 
 AF: 
AC: 
1853
AN: 
44712
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26136
East Asian (EAS) 
 AF: 
AC: 
152
AN: 
39700
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
86258
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53408
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5768
European-Non Finnish (NFE) 
 AF: 
AC: 
9
AN: 
1112012
Other (OTH) 
 AF: 
AC: 
54
AN: 
60396
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.483 
Heterozygous variant carriers
 0 
 162 
 324 
 486 
 648 
 810 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 34 
 68 
 102 
 136 
 170 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.00273  AC: 416AN: 152382Hom.:  11  Cov.: 33 AF XY:  0.00315  AC XY: 235AN XY: 74508 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
416
AN: 
152382
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
235
AN XY: 
74508
show subpopulations 
African (AFR) 
 AF: 
AC: 
27
AN: 
41594
American (AMR) 
 AF: 
AC: 
363
AN: 
15302
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
15
AN: 
5194
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4830
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10622
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
5
AN: 
68046
Other (OTH) 
 AF: 
AC: 
6
AN: 
2116
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.499 
Heterozygous variant carriers
 0 
 22 
 45 
 67 
 90 
 112 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 4 
 8 
 12 
 16 
 20 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
4
AN: 
3478
ClinVar
Significance: Benign/Likely benign 
Submissions summary: Benign:7 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:4 
Feb 09, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
May 28, 2019
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified    Benign:1 
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Kidney disorder    Benign:1 
Oct 01, 2019
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Focal segmental glomerulosclerosis 1    Benign:1 
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
 RBP_binding_hub_radar 
 RBP_regulation_power_radar 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.